COA Documentation Example: What to Check

COA Documentation Example: What to Check

A COA documentation example is most useful when it is read as a batch-specific quality record rather than a generic product attachment. For peptide research, the certificate should allow a researcher to connect the vial in hand to a defined material, a stated analytical result and a traceable batch record. A document that looks scientific but cannot be matched to the product or batch offers limited assurance.

Certificates of Analysis support informed material selection and sound laboratory records. They do not, by themselves, determine whether a compound is appropriate for a particular experimental design, nor do they replace controlled handling, accurate preparation or independent verification where a protocol requires it.

What a Certificate of Analysis is designed to show

A Certificate of Analysis, commonly shortened to COA, records whether a defined batch met specified release criteria. In a well-structured document, the product name, batch or lot number, test methods, results, acceptance criteria and release status work together. The key question is straightforward: can the stated result be traced to the exact material supplied?

For researchers sourcing lyophilised peptides, this matters because the label name alone is not enough. Products can be available in several quantities, batches and packaging formats. Batch-level documentation gives the laboratory a clearer basis for recording what was received, how it was assessed and what was used in a study.

A COA should be treated as one part of a broader documentation set. Product specifications define the expected characteristics. The COA reports the results for a particular batch against those characteristics. Packaging labels, order records and internal receiving logs then preserve the connection after delivery.

COA documentation example: the fields to review

The layout varies between suppliers and analytical laboratories, but the following example shows the information a researcher would normally expect to review.

| Document field | Example entry | Why it matters |
|---|---|---|
| Product name | BPC-157, 5 mg | Confirms the stated material and presentation. |
| Batch number | BPC157-240601 | Must correspond with the vial label and supplied record. |
| Date of manufacture | 01 June 2024 | Supports inventory control and stability assessment. |
| Retest or expiry date | 01 June 2026 | Indicates the supplier's documented review period when stored as specified. |
| Identification method | LC-MS | Provides evidence consistent with the expected molecular mass or identity. |
| Purity method | HPLC | Shows the chromatographic method used to assess purity. |
| Purity result | 99.2% | Should be read alongside the stated acceptance criterion. |
| Acceptance criterion | Not less than 98.0% | Makes the pass or fail decision transparent. |
| Release status | Complies | Indicates whether the batch met the listed specification. |

The values above are illustrative, not a specification for every peptide or supplier. Appropriate analytical methods and acceptance limits depend on the compound, intended research application and the supplier's validated quality approach. A result has more meaning when the document also states how that result was obtained and what criterion it was assessed against.

Product identity and presentation

Begin with the exact product description. Check the peptide name, stated quantity and, where provided, salt form or sequence-related identifier. This is particularly relevant where compounds have similar names, or where the same peptide is stocked at different milligram quantities.

The product description on the COA should agree with the vial label and your purchase record. If a certificate identifies a product broadly but does not show the supplied batch, request clarification before using the material. A generic PDF labelled only with a compound name is not equivalent to batch-specific documentation.

Batch number and traceability

The batch or lot number is the anchor of the record. It should be legible on the vial, outer packaging where applicable, and COA. Differences in punctuation or formatting can occur, but the underlying identifier should be clearly reconcilable.

Record that number at goods-in, then retain it with experimental notebooks, sample preparation records and stored aliquot labels. This practice makes it possible to investigate an unexpected result without relying on memory or a product-page description. It also helps prevent accidental mixing of material from separate batches.

Analytical method and reported result

For peptide materials, HPLC is commonly used to report chromatographic purity, while mass spectrometry may support identity confirmation. A useful COA identifies the method rather than simply presenting an isolated percentage. For example, “Purity: 99%” is more informative when accompanied by “HPLC”, a defined specification and a batch number.

Purity is not a universal measure of fitness for every experimental purpose. It does not independently establish sterility, endotoxin status, biological activity or suitability for human use. Researchers should avoid assuming that a high HPLC purity figure answers questions that require separate tests and separate documentation.

How to assess a COA before laboratory use

A disciplined review does not need to be lengthy, but it should be consistent. Before accepting a peptide into working inventory, compare the certificate with the physical item and your intended protocol.

Check these four points together:

  • The product name and stated quantity match the vial and order record.
  • The batch number on the COA matches the supplied material.
  • The listed test result meets a visible acceptance criterion.
  • The document includes sufficient issue, approval or release information to identify it as a controlled batch record.
A signature, analyst approval, quality release statement or digitally controlled issue reference may be used depending on the supplier's document system. The exact format can vary. What matters is that the document has clear ownership and is not merely an undated marketing claim.

If any element cannot be matched, quarantine the item from active use while the discrepancy is resolved. This is a proportionate step, particularly where multiple vials, repeat experiments or long-running work are involved. It is generally easier to address a documentation question before reconstitution than after samples have entered an experiment.

Common gaps in COA records

Some documents contain genuine results but still provide too little information for effective traceability. A purity percentage without a batch number cannot be tied to a particular vial. A batch number without a named method gives limited context for the result. An acceptance criterion without the actual measured value does not show how close the batch was to the limit.

Dates also deserve careful reading. A manufacture date, analysis date, issue date and retest date refer to different events. An old issue date is not automatically a concern, particularly when storage conditions and retest information are clearly stated. Conversely, a recent certificate does not prove that material was stored appropriately after dispatch. Documentation and handling must support one another.

Be cautious with certificates that use broad language such as “tested” or “high purity” but do not show a result, method or batch link. Transparent quality records allow the reader to assess the claim rather than asking them to accept it without detail.

Keep the COA connected to handling records

Once a batch has been accepted, retain the COA alongside the receiving record and storage information. Note the receipt date, condition of the package, storage location and the name or initials of the person completing the check. For reconstituted material, record the diluent, concentration, preparation date, aliquot identifiers and storage conditions required by the protocol.

This does not need to become an elaborate administrative exercise. A concise, repeatable record is often more valuable than a detailed form completed inconsistently. The aim is to preserve material identity from delivery through to experimental use.

At 23 Bio Labs, batch references and Certificate of Analysis documentation are intended to support this practical chain of traceability for research products. Researchers should still review the records against their own laboratory requirements, particularly where an institution has defined receiving, storage or quality-control procedures.

When a COA needs further questions

The right level of scrutiny depends on the research context. Early-stage exploratory work may require confirmation of identity, batch and purity only. Work involving sensitive assays, comparative studies or externally reported findings may justify further questions about chromatograms, mass spectra, residual solvents, moisture content or other compound-specific attributes.

Ask for clarification when a result is unclear, a batch identifier does not match, the method is absent, or the product presentation differs from the certificate. A transparent supplier should be able to explain what the document represents and whether additional records are available. Do not infer attributes that are not explicitly tested or stated.

A carefully reviewed COA is a small operational control with a significant effect on research confidence. Match it to the vial, preserve the batch record and let the documented evidence guide the next step in your laboratory workflow.

Back to blog